•     Testimonials      •     Verdicts      •     Bios      •

Contact Us

Crestor
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Has Rhabdomyolysis been diagnosed?


If yes, when was Rhabdomyolysis diagnosed?

Please further describe side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


AddThis Social Bookmark Button
DOWNLOAD OUR CRESTOR INFORMATION PACKAGE

Injured By Crestor?

Crestor has been linked to kidney damage and kidney failure. On October 22, 2004, the consumer group Public Citizen said twenty-nine patients who took AstraZeneca's cholesterol drug Crestor developed kidney damage. Crestor has also been linked to the potentially fatal disease Rhabdomyolysis.

Consumer group, Public Citizens states, the rate of reported kidney problems is approximately 75 times higher with Crestor than with all other drugs in the same class combined. According to its analysis, there have been 6.4 reports of acute kidney failure or kidney damage for every 1 million Crestor prescriptions filled.

Crestor has been linked to numerous cases of Rhabdomyolysis, a rare muscle destroying disease. Crestor is in the popular family of cholesterol-lowering drugs called Statins. Several years ago Baycol, another popular statin drug, was banned for its link to Rhabdomyolysis.

Crestor Side Effects were Evident Before it was Approved

Crestor was approved by the FDA in August 2003, after a delay because of safety concerns. During FDA studies seven cases of the potentially fatal, muscle-destroying condition Rhabdomyolysis occurred.

These studies also linked Crestor with cases of kidney abnormalities not seen with other Statins. The FDA decided to approve Crestor but at lower dosages. However, records from the FDA and health agencies in Canada and Britain show life-threatening side effects occur even at those lower doses.

Rhabdomyolysis is a serious disorder that causes kidney damage resulting from toxic effects of the contents of muscle cells. Myoglobin is an iron-containing pigment found in the skeletal muscle. When the skeletal muscle is damaged, the Myoglobin is released into the bloodstream. It is filtered out of the bloodstream by the kidneys. Myoglobin may obstruct the structures of the kidney, causing damage such as acute tubular necrosis or kidney failure.

If you or a loved one took Crestor and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.

CrestorRSS Feed

Crestor Does Not Reduce Heart Failure Deaths, Study Says

Nov 29, 2007 | Parker Waichman Alonso LLP
Crestor, a cholesterol lowering statin, does not appear to reduce deaths in heart failure patients, according to a new study published in the New England Journal of Medicine.   The results of the 5,000 person CORONA study are a big blow to AtraZeneca, which had hoped to market Crestor as the first statin to show clear benefits in treating chronic heart conditions in the elderly.Crestor was approved by the Food & Drug Administration (FDA) in 2003.  It is a member of a drug...

Study, FDA Differ On Cholesterol Drug Crestor

May 24, 2005 | Washington Post
The powerful cholesterol-lowering drug Crestor is significantly more likely than other statins to cause muscle deterioration that can lead to kidney disease and failure, according to a study in the American Heart Association's journal, Circulation.The conclusion is at odds with the most recent recommendation of the Food and Drug Administration, which in March rejected a petition to remove Crestor from the market. At the time, the FDA said Crestor appeared to be no more dangerous than other...

Study Finds More Side Effects From Crestor Than Other Statins

May 24, 2005 | Los Angeles Times
The widely used cholesterol-lowering drug Crestor has at least twice the incidence of side effects as other drugs in the statin family.The findings suggest that Crestor, manufactured by AstraZeneca, should probably be reserved for patients who have had a hard time lowering their overall cholesterol levels with other statins, said Dr. Richard H. Karas of the Tufts-New England Medical Center in Boston, who led the study.The study was based on adverse reactions to statins reported to the Food and...

New Fears Over Cholesterol Drug

May 24, 2005 | The Guardian
AstraZeneca's controversial drug Crestor produces more than twice as many side effects as other common cholesterol lowering treatments, a study by a leading medical journal has concluded.The report's authors said the analysis raises concerns about the drug's safety, and suggest that alternatives should be used before Crestor is prescribed in order to cut the risk.The pharmaceuticals firm has fought calls for the drug to be banned from US consumer group Public Citizen, and yesterday said it...

Study On Crestor Contradicts FDA

May 24, 2005 | Philadelphia Inquirer
Researchers reported yesterday that more people suffered serious side effects from the cholesterol drug Crestor than from other drugs, and recommended that millions of people use it only as a last resort.The Tufts University study contradicted findings by the U.S. Food and Drug Administration and will not help Crestor's maker, AstraZeneca P.L.C. with U.S. operations in Wilmington build Crestor into the blockbuster product it has intended.Crestor was the first cholesterol-lowering drug in a...

More Crestor News